Post-Market Security Management
Cybersecurity responsibilities continue throughout the device lifecycle with ongoing monitoring, vulnerability management, and customer communication requirements.
Getting a medical device cleared is the start of your cybersecurity obligations, and this chapter covers everything that comes after. FDA's 2016 postmarket cybersecurity guidance, now reinforced by Section 524B of the FD&C Act, expects manufacturers to monitor for new vulnerabilities, assess and respond to risk, patch deployed devices, and keep customers and regulators informed for as long as the device is in clinical use. The chapter opens with the shared responsibility model: manufacturers develop patches and communicate risk, healthcare facilities apply updates and secure their networks, users follow procedures and report problems, and FDA monitors safety signals and enforces requirements.
The middle sections walk through the operational core of a post-market program. You'll see how to build a vulnerability monitoring program around your SBOM, using sources like the National Vulnerability Database and the CISA Known Exploited Vulnerabilities catalog, with monitoring frequency tiered by component risk. From there the chapter covers structured vulnerability assessment (exploitability analysis, impact analysis, and risk scoring with the MITRE medical device CVSS rubric), patch development and secure distribution, and coordinated vulnerability disclosure, including a sample CVD policy and disclosure timelines researchers will actually accept.
The later sections cover the supporting functions that keep the program running: H-ISAC information sharing, customer security advisories with notification timelines based on risk, incident response roles and severity classification, and the metrics that tell you whether any of it works, like time to assess, time to patch, and deployment rates. The chapter closes with resource planning for a sustainable team and budget, five common pitfalls (starting with "set and forget" monitoring), emerging challenges like AI vulnerabilities and ransomware, and how to assemble a post-market playbook you can exercise before you need it for real.
- Section 5.1 · 1 minIntroduction: Security Doesn't End at LaunchMedical device cybersecurity continues for the entire life of the device. FDA expects manufacturers to monitor, assess, and respond to vulnerabilities for as long as a device is in clinical use, and u…
- Section 5.2 · 1 minThe Post-Market Security LandscapePost-market security for medical devices means continuous vulnerability monitoring, risk assessment, patching, and stakeholder communication for the life of the device, with manufacturers, healthcare …
- Section 5.3 · 2 minBuilding Your Vulnerability Monitoring ProgramA vulnerability monitoring program starts with an accurate SBOM, watches a defined set of sources (NVD, the CISA KEV catalog, vendor advisories) on a schedule tiered to component risk, and routes anyt…
- Section 5.4 · 2 minVulnerability Assessment and ResponseAssess every new vulnerability in four steps: triage whether it affects your device at all, analyze exploitability in your actual deployment, analyze the patient safety and security impact, then score…
- Section 5.5 · 2 minDeveloping and Deploying PatchesPatching a medical device follows the same change control as any other software change: reproduce the issue, develop the fix, then run security, safety, and regression testing before release. Distribu…
- Section 5.6 · 2 minCoordinated Vulnerability DisclosureCoordinated vulnerability disclosure (CVD) gives security researchers a sanctioned way to report flaws in your devices, and gives you time to develop a fix before the details go public. At minimum you…
- Section 5.7 · 1 minInformation Sharing and AnalysisInformation sharing means joining the Health-ISAC to receive threat intelligence and early warnings, and contributing your own lessons learned without exposing unpatched details or customer specifics.…
- Section 5.8 · 2 minCustomer CommunicationCustomer communication for device security runs on advisories: clear, timely notices that name the affected products and versions, describe the vulnerability and its clinical impact, and tell customer…
- Section 5.9 · 1 minIncident ResponseIncident response for medical devices follows the standard cycle of assess, contain, eradicate, recover, and learn, with two additions specific to healthcare: a clinical safety role that judges patien…
- Section 5.10 · 1 minSecurity Metrics and Continuous ImprovementMeasure your post-market program with a small set of indicators: time to discover, assess, and patch vulnerabilities, incident detection and resolution times, and program health measures like SBOM acc…
- Section 5.11 · 1 minResource PlanningBuild a sustainable team:
- Section 5.12 · 1 minCommon Post-Market Pitfalls
- Section 5.13 · 1 minFuture-Proofing Your ProgramPrepare for evolving threats:
- Section 5.14 · 1 minBuilding Your Post-Market PlaybookCreate and maintain:
- Section 5.15 · 1 minKey Takeaways1. Post-market security is a marathon, not a sprint - Build sustainable processes
See how your device measures up
Take the free FDA 524B readiness assessment and get a personalized gap report covering this chapter and more.
Check Your Readiness